Attention-Deficit/Hyperactivity Disorder and Substance Abuse
Abstract
Attention-deficit/hyperactivity disorder (ADHD) and substance use disorders are inextricably intertwined. Children with ADHD are more likely than peers to develop substance use disorders. Treatment with stimulants may reduce the risk of substance use disorders, but stimulants are a class of medication with significant abuse and diversion potential. The objectives of this clinical report were to present practical strategies for reducing the risk of substance use disorders in patients with ADHD and suggestions for safe stimulant prescribing.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The available evidence regarding dextroamphetamine's use in preschool-aged children with ADHD is not adequate to recommend it as an initial ADHD medication treatment.
“Hence, the available evidence regarding dextroamphetamine’s use in preschool-aged children with ADHD is not adequate to recommend it as an initial ADHD medication treatment at this time.80”
From Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents (2019) · cites this paper as [80]
No citation lists for this paper
No citation lists for this paper yet — checked again daily.
References 70 · Cited by 131
- Authors
- Harstad, E., Levy, S., COMMITTEE ON SUBSTANCE ABUSE, Levy, S., Ammerman, S. D., Gonzalez, P. K., Ryan, S. A., Siqueira, L. M., & Smith, V. C.
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2014-07-01
- Volume
- 134
- Issue
- 1
- Pages
- e293-e301
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W1975579264
- Cited by
- 131
- References
- 70
- Citations by year
- 2026: 4 · 2025: 15 · 2024: 12 · 2023: 5 · 2022: 6 · 2021: 8 · 2020: 16 · 2019: 14 · 2018: 8 · 2017: 14 · 2016: 17 · 2015: 4 · 2014: 4 · 2012: 1
- FWCI
- 1.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- PEDIATRICS (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- attention deficit hyperactivity disorder, substance use disorders, stimulant medication, stimulant abuse, drug diversion, prescribing safety, children, risk mitigation strategies
- MeSH terms
- Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Mental Disorders, Child, Humans, Practice Guidelines as Topic, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
